[1]CurrentPatentAssignee:RIPKAAMY-WO2021/257754,2021,A1Locationinpatent:Page/Pagecolumn225
[2]CurrentPatentAssignee:RIPKAAMY-WO2021/257754,2021,A1Locationinpatent:Page/Pagecolumn225
224776-16-3
1354970-43-6
936939-88-7 | [3-(Pyridin-2-yl)-1,2,4-oxadiazol-5-yl]methanamine | AA00IHO8 | MFCD09034269
94-71-3 | 2-Ethoxyphenol | AA00IHU6 | MFCD00002187
943843-61-6 | 3-(3-Fluorophenyl)pyrrolidine hydrochloride | AA00II1N | MFCD03094756
944998-15-6 | 3-(6-Fluoropyridin-3-yl)propanoic acid | AA00II82 | MFCD18803196
947274-14-8 | 3-(3-Methoxypropoxy)benzaldehyde | AA00IIEV | MFCD12798838
949376-83-4 | 1-(4-Cyanophenyl)-N-cyclopropylmethanesulfonamide | AA00IIL0 | MFCD10503523
952138-13-5 | 4,7-Dichloro-1,6-naphthyridine | AA00IIR5 | MFCD11044711
95399-95-4 | 2,3-Dichloro-6-fluorobenzaldehyde | AA00IIY5 | MFCD04115870
956-02-5 | 1-(4-Chlorophenyl)-3-phenylprop-2-en-1-one | AA00IJ57 | MFCD00016343
957035-33-5 | 3-(4-Bromo-1H-pyrazol-1-yl)-6-chloropyridazine | AA00IJAK | MFCD09475884